Cargando...

Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate

A trial is reported of the effects of giving clofibrate to prevent progression of pre-existing ischaemic heart disease. There were two groups randomly distributed between clofibrate (350 patients) and placebo (367 patients) regimens. The trial lasted about six years and was conducted in 19 hospitals...

Descrición completa

Gardado en:
Detalles Bibliográficos
Formato: Artigo
Idioma:Inglês
Publicado: 1971
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1799730/
https://ncbi.nlm.nih.gov/pubmed/4943606
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!